Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25113

1.

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

Kumar P, Ravi R, Sundar G, Shiach C.

Cardiovasc Intervent Radiol. 2016 Dec 2. [Epub ahead of print]

PMID:
27913856
2.

Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report.

Rankin J, Nagar M, Crosby J, Toomari N, Pietras R, Ben-Zur UM.

J Med Case Rep. 2016 Dec 3;10(1):346.

PMID:
27912791
3.

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.

Arnao V, Riolo M, Tuttolomondo A, Pinto A, Fierro B, Aridon P.

Expert Rev Neurother. 2016 Dec 2. [Epub ahead of print]

PMID:
27911120
4.

Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers.

Salem AH, Hu B, Freise KJ, Agarwal SK, Sidhu DS, Wong SL.

Clin Drug Investig. 2016 Dec 2. [Epub ahead of print]

PMID:
27910036
5.
6.

Which Factors Influence Resident Physicians to Prescribe NOACs to Patients with Non-Valvular Atrial Fibrillation?

Oqab Md Frcpc Z, F McIntyre Md Frcpc W, M Hopman Ma W, Baranchuk Md Facc Frcp A.

J Atr Fibrillation. 2016 Aug 31;9(2):1462.

7.

Validation Of The HAS-BLED Tool In Atrial Fibrillation Patients Receiving Rivaroxaban.

Ew G, D P, D D, J Y, Re H, D W.

J Atr Fibrillation. 2016 Aug 31;9(2):1461.

8.

A Comparison Between NOACs and Warfarin on Time to Elective Cardioversion.

Krothapalli Md S, Bhave Md Fhrs PD.

J Atr Fibrillation. 2016 Aug 31;9(2):1451. Review.

9.

The Role Of NOACs in Atrial Fibrillation Management: A Qualitative Study.

Kirley Md Ms K, Rao Md G, Bauer Bs V, Masi Md PhD C.

J Atr Fibrillation. 2016 Jun 30;9(1):1416.

10.

Internal Jugular Vein Complete Thrombosis After Dual Chamber Pacemaker Implant.

Placci A, Mattioli M, Notarangelo MF, Gonzi G, Zardini M.

J Atr Fibrillation. 2016 Jun 30;9(1):1406.

11.

A Comparison Between Dabigatran and Warfarin on Time to Elective Cardioversion.

Basto PharmD AN, Fewel PharmD NP, Md RG, Stock PhD EM, PharmD MT.

J Atr Fibrillation. 2016 Apr 30;8(6):1355.

12.

The Cost Effectiveness of LAA Exclusion.

Kreidieh B, Rodríguez-Mañero M, Ibarra-Cortez SH, Schurmann P, Valderrábano M.

J Atr Fibrillation. 2016 Feb 29;8(5):1374. Review.

13.

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.

Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S.

Stroke. 2016 Dec 1. pii: STROKEAHA.116.015150. [Epub ahead of print]

PMID:
27909200
14.

Conservative Treatment of Chronic Subdural Hematoma in HIV-Associated Thrombocytopenia with Tranexamic Acid.

Kutty RK, Peethambaran AK, Sunilkumar, Anilkumar M.

J Int Assoc Provid AIDS Care. 2016 Dec 1. pii: 2325957416680294. [Epub ahead of print]

PMID:
27909114
15.

Efficacy and safety of TC-325 (HemosprayTM) for non-variceal upper gastrointestinal bleeding at Middlemore Hospital: the early New Zealand experience.

Giles H, Lal D, Gerred S, Casey P, Patrick A, Luo D, Ogra R.

N Z Med J. 2016 Dec 2;129(1446):38-43.

PMID:
27906917
16.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW.

Cochrane Database Syst Rev. 2016 Dec 1;12:CD008500. [Epub ahead of print] Review.

PMID:
27906452
17.

Atrial fibrillation: A safe alternative to warfarin plus DAPT after PCI?

Ummarino D.

Nat Rev Cardiol. 2016 Dec 1. doi: 10.1038/nrcardio.2016.201. [Epub ahead of print] No abstract available.

PMID:
27905477
18.

Frequency and cost of acute surgical admissions in over-anticoagulated patients: over-anticoagulation in the community.

Nimmo M, Armstrong D, Koea JB.

ANZ J Surg. 2016 Dec 1. doi: 10.1111/ans.13851. [Epub ahead of print]

PMID:
27905180
19.

Improvement of time in therapeutic range with warfarin by pharmaceutical intervention.

Víquez-Jaikel A, Victoria Hall-Ramírez, Ramos-Esquivel A.

Int J Clin Pharm. 2016 Nov 30. [Epub ahead of print]

PMID:
27905076
20.

The effect of clinical supervision model on high alert medication safety in intensive care units nurses.

Esfahani AK, Varzaneh FR, Changiz T.

Iran J Nurs Midwifery Res. 2016 Sep-Oct;21(5):482-486.

Items per page

Supplemental Content

Loading ...
Support Center